4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-065325
Chief Commercial Officer sold 325 shares at $4.39 ($1,427)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Marshak Richard Chief Commercial Officer | 2026-10-05 | Sale | −325 | $4.39 | $1,427 | 127,994 | D |
| Open-market sales · 325 sh · avg $4.39 · $1,427 | |||||||
Loading xslF345X06/wk-form4_1791403362.xml…